Stephanie Graff, MD, FACP
- Director of breast oncology, Lifespan Cancer Institute at the Legorreta Cancer Center, Brown University
- Associate professor of medicine, Warren Alpert School of Medicine
- Co-leads the Breast Cancer Translational Research Disease Working Group
- Speaker, Ask the expert: Updates from the 2023 San Antonio Breast Cancer Symposium (SABCS)
Dr. Stephanie Graff, MD, FACP, is the director of breast oncology at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University in Providence, Rhode Island. She is an associate professor of medicine at the Warren Alpert School of Medicine and co-leads the Breast Cancer Translational Research Disease Working Group.
Prior to joining Lifespan/Brown in 2021, she was associate director of the breast cancer research program at Sarah Cannon Research Institute and national breast lead for the Sarah Cannon Cancer Network's clinical programs. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research and is a contributing author on the seventh edition of Dr. Susan Love's Breast Book.
Dr. Graff is board certified in medical oncology, hematology, and internal medicine. She completed a breast oncology sub-fellowship at the University of Kansas. She has broad experience as a principal investigator on numerous clinical trials across all phases of drug development, in addition to work in translational research, genomics, and gender bias. In addition to scientific publications, she is an award-winning writer, social media influencer, and sought-after public speaker. She serves editorial roles at Cancer Medicine, Journal of Clinical Oncology, American Journal of Clinical Oncology, and Oncology Times.
Dr. Graff has received the Frist Humanitarian Award for her work in the community, Healio Disruptive Innovator Woman Disruptor of the Year in 2022, and the RI American College of Physicians' Benjamin L. Sapers Memorial Award for her "passion for pedagogy, academic rigor, empathy and humanism."
Ultimately, Dr. Graff is passionate about connecting with her patients to provide personalized, comprehensive oncology care, advancing breast cancer research, and breast cancer prevention.
Targeted therapies are treatments that target specific proteins or markers on or within cancer cells that help the cells to grow. They look for a specific feature of a cancer cell, attach to it, and destroy it. Only cancers with that feature will respond to the therapy.